Intellipharmaceutics International Inc. (Nasdaq: IPCI) is down 16.9% in pre-open trade after the company announced that it intends to offer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE